Atlas Trials

Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria

Clinical trial NCT04583475 · COMPLETED

Trial details

NCT number
NCT04583475
Sponsor
University Hospital, Lille
Status
COMPLETED
Study type
OBSERVATIONAL
Spontaneous Urticaria, Chronic
Start date
2021-02-25
Primary completion
2023-06-22
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.